Clinical trial results are expected by end of 2026 to guide dose selection for future ALS/MND and Parkinson’s studies. Credit ...

Ribupatide (KAI-9531) aims to address critical need for greater weight loss, especially for people living with a BMI of 35 kg ...

Clinical trials are studies that test new medical interventions, such as a new type of drug, surgery, or medical device, on human volunteers. They aim to determine whether the new treatment option is ...

Johnson & Johnson announced positive topline results from its Phase 2 randomized placebo-controlled JASMINE study. The drug ...

Lynk’s zemprocitinib commercial partner, Simcere, will now continue the JAK inhibitor’s development across China in RA.

Arvinas plans Phase 3 trials for vepdegestrant combinations in breast cancer and initiates trials for new Parkinson's disease treatments. Arvinas, Inc. announced its plans to begin two Phase 3 ...

Early-phase clinical trials, those first-in-human studies, are where years of research and millions in investment meet the ...

Publication Highlights Impressive Weight Loss of Up to 14.7% from Baseline After 13 Weeks of Treatment; No Plateau Observed VK2735 Currently Being Evaluated in VANQUISH ...

Clinical trials move through four structured phases, from safety testing to long-term effects. Adaptive, basket, and umbrella trials are making cancer research faster and more flexible. Molecular ...

Phase 1b study to evaluate combination of zongertinib and zanidatamab in HER2-positive breast cancer patients Ingelheim, Germany– 12 January, 2026 – Boehringer Ingelheim today announced a strategic ...

After a lengthy downturn, the biotech industry finally gathered momentum in 2025. Key readouts in obesity, infectious disease ...